Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001213900-25-046977

Director sold 2,000,000 shares at $2.71 ($5,425,800)

From the SEC's structured data for this filing

Trades in this filing

M33 Growth I L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-20 Sale : show line 1 in the form −1,796,468 $2.71 $4,873,638 14,624,233 D
2025-05-20 Sale : show line 2 in the form −203,532 $2.71 $552,162 1,349,048 I
Open-market sales · 2,000,000 sh · avg $2.71 · $5,425,800
Loading xslF345X05/ownership.xml…